Essential Tremor Clinical Trial
Official title:
Transcranial Direct Current Stimulation of the Motor Cortex in Essential Tremor : A Randomized Controlled Pilot Study
The current research is aimed at using Transcranial Direct Current Stimulation (tDCS) as
complementary therapeutic tool in the treatment of essential tremor. Patients will be
randomized into two groups (tDCS-cathode vs. tDCS-sham) according to detailed protocol. Main
outcome will be measured by the change in tremor amplitude using an accelerometer pre and
post cathodal tDCS of the motor cortex.
A total of 40 patients ought to be enrolled as specified in methodology. Secondary outcomes
will assess TRG essential tremor rating assessment scale (TETRAS) as well as clinical
monitoring.
Essential tremor (ET) is a common progressive neurological disorder and is the most common
movement disorder. Worldwide , up to 5% of the population suffer from this disorder with an
increased incidence with advanced age.
The proposed mechanism that underlies ET, the central oscillating network, is mainly composed
of the olivocerebellar system, thalamus and motor cortex. An interruption in this circuit
limits the ability of the cortex to reorganize and restore ET. a case of 76 year old female
with essential tremor that disappeared following a cortico-subcortical prerolandic stroke
despite complete motor recovery highlights the role of the motor cortex in the production and
possible therapeutic role of the transcranial direct current stimulation.
Study design A randomized, sham-controlled, double blind and crossover study.
Study procedure:
The first visit is an inclusion visit Prior to starting the first tDCS session, the patient
will be asked to fill his/her first TRG essential tremor assessment (TETRAS) scale. The
physician will then quantitatively analyze the tremor on the most affected side using an
accelerometer. Cathodal tDCS will be administered on the area representing the primary motor
cortex and the anode over the contralateral supraorbital area. tDCS stimulation (cathodal and
sham) will be done daily for 5 consecutive days during weeks 1 and 5. Each stimulation
session will last 30 minutes. tDCS will be performed while the patient is at rest, without
any concurrent cognitive or motor task.The two tDCS sessions will be separated by a 23 day
washout period.
Patient will be asked to fill out their TETRAS at days 1 and 5 of each tDCS session (cathodal
and sham), and days 12 and 19 after each tDCS session (cathodal and sham).
Accelerometer assessment of the tremor will be performed at days 1 and 5 of each tDCS
stimulation session (cathodal and sham).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT05381688 -
VIM DBS Respiratory Modulation: N-of-1 Trial
|
||
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Completed |
NCT02277106 -
Evaluate SAGE-547 in Participants With Essential Tremor
|
Phase 2 | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Terminated |
NCT02894567 -
Evaluation of Directional Recording and Stimulation Using spiderSTN
|
N/A | |
Terminated |
NCT02678429 -
Atlas Predicted DBS Settings in Essential Tremor
|
N/A | |
Completed |
NCT02523807 -
Tremor Monitoring Device
|
N/A | |
Active, not recruiting |
NCT02255929 -
Gamma Knife Radiosurgery for Treatment of Essential Tremor
|
N/A | |
Completed |
NCT01223144 -
Decision-making and Emotion Recognition in Essential Tremor
|
N/A | |
Completed |
NCT00906412 -
Ventrointermediate Nucleus (VIM DBS) and Working Memory
|
N/A | |
Recruiting |
NCT05214222 -
Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma
|
Phase 2 | |
Completed |
NCT03051178 -
Wearable Sensor for Responsive DBS for ET
|
N/A | |
Recruiting |
NCT03795935 -
Relief From Side Effects: Clinical Use of Electrodes With Direction
|
N/A | |
Not yet recruiting |
NCT06036368 -
Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor
|
N/A | |
Recruiting |
NCT05897775 -
Coordinated Reset Deep Brain Stimulation for Essential Tremor
|
Phase 1 | |
Recruiting |
NCT05968976 -
Multicentre RCT of Awake Versus Asleep Tractography Based DBS for ET
|
N/A | |
Completed |
NCT06314139 -
Tolerability and Efficacy of Continuous Theta-burst Stimulation for Essential Tremor: A Randomized Study.
|
N/A | |
Recruiting |
NCT04501133 -
Sensory-specific Peripheral Stimulation for Tremor Management
|
N/A | |
Active, not recruiting |
NCT03560622 -
Functional Neuroimaging Feedback for Focused Ultrasound Thalamotomy
|
N/A | |
Completed |
NCT00368199 -
Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
|
N/A |